LBG’s Andrew Harmon is speaking at the BioProcess Insider’s State of the Industry Discussion. This discussion is being presented at BPI East 2024 in Boston.
This engaging session will cover critical topics such as:
- The turnaround in the funding environment and how that is affecting the supply sector
- Major M&A over the past few months in the outsourced and supplier space
- The widening modality focus of the industry and how vendors and CDMOs are responding
- Macroeconomic factors (BIOSECURE and China, specifically)
This discussion promises to provide valuable insights for professionals navigating the complexities of the biopharma landscape!
Connect with Andrew to learn more about this topic.
